# Isarna Therapeutics GmbH: Research, Graefelfing, Germany

> Isarna Therapeutics GmbH: Isarna Therapeutics GmbH is a clinical-stage biotechnology company based in Gräfelfing, near Munich, Germany.

Source: https://millionrounds.com/startup/isarna-therapeutics-gmbh (Millionrounds; every figure on the page links to its filing or article)

Germany · [Research startup](https://millionrounds.com/companies)

# Isarna Therapeutics GmbH

Isarna Therapeutics GmbH is a clinical-stage biotechnology company based in Gräfelfing, near Munich, Germany.

Email

Funding reported Last round: Undisclosed round

Research Graefelfing, Germany

Follow Isarna Therapeutics GmbH and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fisarna-therapeutics-gmbh)

Company summary

- **Founded:** 1998 28 years old
- **Team:** 7 1 to 10 people
- **Funding reported:** 124.2M as listed, currency not stated
- **Last round:** Undisclosed round Apr 2014

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Isarna Therapeutics GmbH has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Isarna Therapeutics GmbH

Isarna Therapeutics GmbH is a clinical-stage biotechnology company based in Gräfelfing, near Munich, Germany.

The company specializes in developing next-generation antisense oligonucleotide therapies that target TGF-β signaling pathways. These therapies aim to treat retinal diseases, fibrotic liver conditions, and cancer. Isarna is led by experienced executives, including COO Dr. Rene Rückert and CMO Prof. Marion Munk, and is currently preparing for Phase 2a studies. The company's lead product, ISTH0036, is designed to selectively inhibit TGF-β2 mRNA and protein, showing promising safety and efficacy in early trials. Isarna's pipeline includes additional assets targeting various TGF-β isoforms for conditions such as liver cancer and nonalcoholic steatohepatitis (NASH). The company focuses on advancing its proprietary antisense agents and is actively seeking partnerships and investment to support its clinical development efforts.

## What company datasets say Isarna Therapeutics GmbH raised

Funding, as reported

Reported in all **124.2M** in the source's currency

Rounds **7**

Last round **Undisclosed round**

Last round size **7.6M**

Last round date **Apr 2014**

Investors listed **6**

## On a portfolio page

Investors who name them

- [MIG Fonds](https://millionrounds.com/fund/mig-fonds)

Each firm lists Isarna Therapeutics GmbH on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care tgf-2 antisense biotechnology research antisense compound portfolio fibrotic disease therapy cancer therapy antisense oligonucleotides for fibrosis fibrosis phase 2a clinical trial fibrotic liver disease targeted therapy antisense compounds hospital & health care antisense drugs for ophthalmology antisense oligonucleotide medical

Built with from their website

Google Maps WordPress.org Font Awesome Elementor Viewport Meta Element UI MapPress Pro Essential Addons for Elementor Underscore.js Google Maps Platform

+8 more

Priority Hints Google Font API Microsoft Exchange MySQL PrimeNG Microsoft 365 Apps & Services Mobile Friendly jQuery

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Bayern
- **Revenue:** 15.7M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/isarna-therapeutics)

## Research in Germany

Startups like it

- [**SphingoTec** Hennigsdorf · founded 2002 *Raised*](https://millionrounds.com/company/sphingotec)
- [**mbiomics GmbH** Neuried · founded 2020 *Raised*](https://millionrounds.com/company/mbiomics-gmbh)
- [**PreOmics** Planegg · founded 2016 *Raised*](https://millionrounds.com/company/preomics)
- [**CatalYm GmbH** Planegg · founded 2016](https://millionrounds.com/startup/catalym-gmbh)
- [**Cellex Cell Professionals** Cologne · founded 2001](https://millionrounds.com/startup/cellex-cell-professionals)
- [**NVision Quantum Technologies** Ulm · founded 2015](https://millionrounds.com/startup/nvision-quantum-technologies)
- [**Resolve Biosciences** Monheim am Rhein · founded 2020](https://millionrounds.com/startup/resolve-biosciences)
- [**SciRhom** Planegg · founded 2016](https://millionrounds.com/startup/scirhom)

## Is this your company?

Add your raise, your deck and your story, and put Isarna Therapeutics GmbH in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)